Improved noninvasive fetal variant calling using standardized benchmarking approaches
The technology of noninvasive prenatal testing (NIPT) enables risk-free detection of genetic conditions in the fetus, by analysis of cell-free DNA (cfDNA) in maternal blood. For chromosomal abnormalities, NIPT often effectively replaces invasive tests (e.g. amniocentesis), although it is considered...
Main Authors: | Tom Rabinowitz, Shira Deri-Rozov, Noam Shomron |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037020305572 |
Similar Items
-
Genome-wide noninvasive prenatal diagnosis of monogenic disorders: Current and future trends
by: Tom Rabinowitz, et al.
Published: (2020-01-01) -
Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01) -
Fetal sex discordance
by: Álvaro López Soto, et al.
Published: (2020-09-01) -
Obstetrical provider knowledge and attitudes towards cell–free DNA screening: results of a cross-sectional national survey
by: Wilson V. Chan, et al.
Published: (2018-01-01) -
Non-invasive prenatal testing: a new era in fetal medicine
by: Bevilacqua, Elisa
Published: (2020)